- Rheumatoid Arthritis Slideshow Pictures
- Joint-Friendly Exercises Slideshow Pictures
- Take the RA Quiz
- Patient Comments: Reactive Arthritis - Symptoms
- Patient Comments: Reactive Arthritis - Personal Experience
- Patient Comments: Reactive Arthritis - Non-Joint Symptoms
- Find a local Rheumatologist in your town
- Reactive arthritis facts
- What is reactive arthritis?
- What causes reactive arthritis?
- What are risk factors for developing reactive arthritis?
- What are reactive arthritis symptoms and signs?
- How do health-care professionals diagnose reactive arthritis?
- What is the treatment for reactive arthritis?
- What is the prognosis of reactive arthritis?
- Is it possible to prevent reactive arthritis?
- What does the future hold for reactive arthritis?
What is the prognosis of reactive arthritis?
The outlook for reactive arthritis is generally very good. Today, there are many effective treatments. The outlook is best when the disease is diagnosed and treated aggressively early on. When a specific cause is identified and eradicated, it is sometimes possible to completely cure reactive arthritis. Complications, such as eye, skin, or prostate disease, can require comanagement with appropriate specialists, including ophthalmologists, dermatologists, and urologists as well as rheumatologists.
Is it possible to prevent reactive arthritis?
Yes. Reactive arthritis can be prevented, to some extent, by avoiding sexual infection and by storing food properly and cooking it properly.
What does the future hold for reactive arthritis?
In the future, new medications will be developed that are more specific in the treatment of reactive arthritis. Trials with long-term antibiotic treatment are under way, and it is possible that these may be especially effective in reactive arthritis that is associated with chlamydia infection.
The TNF-blockers, such as etanercept (Enbrel) and infliximab (Remicade), have potential for treating severe, resistant reactive arthritis. These drugs may improve both the joint and non-joint areas of inflammation. Further studies of these drugs are under way.
For further information about reactive arthritis, please visit the following site: Arthritis Foundation.
You can also contact:
The Arthritis Foundation
P.O. Box 19000
Atlanta, Georgia 30326
or contact your local chapter
National Arthritis and Musculoskeletal and Skin Diseases Clearinghouse
Bethesda, Maryland 20892
Fauci, A.S., and C.A. Langford. Harrison's Rheumatology. New York: McGraw-Hill Medical Publishing, 2006.
Koopman, William, et al., eds. Clinical Primer of Rheumatology. Philadelphia: Lippincott Williams & Wilkins, 2003.
Ruddy, Shaun, et al., eds. Kelley's Textbook of Rheumatology. Philadelphia: W.B. Saunders Co., 2000.